BVS vs CAT · rev $573.3M vs P/E 48, rev $20.54B
Bioventus Inc (BVS) versus Caterpillar Inc (CAT) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported CAT revenue for 2026-06-30 was $20.54B. Net income was $3.59B. Revenue was up 18.0% from 2026-03-31 to 2026-06-30. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
BVS currently screens at market cap $495.1M. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Not investment advice. Open the BVS and CAT stock pages for the full models.
Not investment advice.